Introduction
Critical to the effective diagnosis and management of disease is information on its prevalence in a particular geographic area such as the country of Italy. Alpha-1-antitrypsin deficiency (AAT Deficiency) is one of the most common serious hereditary diseases in the world, since its affects all major racial subgroups worldwide. There are at least 120.5 million carriers and deficient subjects worldwide for the two most prevalent deficiency alleles PIS and PIZ [1] . This genetic disease is known to exist in Italy [2] , and it is related to a high risk for development of jaundice in infants, liver disease in children and adults, and pulmonary emphysema in adults [3] .
Alpha-1-antitrypsin (AAT) is a 52 kDa alpha-1-glycoprotein, composed of 394 amino acid residues and 3 asparagine-linked complex carbohydrate side chains [4] . It is produced mainly by hepatocytes and secreted into the blood, where it acts as a circulating serine protease inhibitor whose principal substrate is neutrophil elastase (NE) [5] . The AAT gene locus is located on the long arm of chromosome 14, has been mapped to chromosome 14q31-32.3 [6] , and is organized in 3 non-coding (Ia, Ib and Ic) exons and 4 (II, III, IV and V) coding exons [7] . The normal gene is designated PIM, and about 100 normal and defective genetic variants are recognizable by isoelectric focusing (IEF) [8, 9] . The two most frequent deficient alleles are PIS (which expresses approximately 50-60% of AAT) and PIZ (which expresses approximately 10-20% of AAT) [6, [10] [11] [12] .
AAT Deficiency is a heritable autosomal recessive metabolic disease that results in the syn-thesis and secretion of a defective AAT. AAT Deficiency state by itself is not a disease, but a predisposition to later development of several diseases, both in children and adults. Hepatic accumulation of AAT polymers leads to low serum levels of AAT protein and these, in conjunction with other genetically determined characteristics and environmental influences, might result in early onset of panlobular pulmonary emphysema in adults, especially in habitual tobacco smokers [4, 13, 14] ; severe liver diseases in newborns, children and adults [12, 15] , and it is also suspected that AAT Deficiency could promote bronchial asthma [16] , bronchiectasis [17] , multisystemic vasculitis [18] , necrotizing panniculitis [19, 20] , rheumatoid arthritis [21] , intracranial arterial dissections [22] , multiple sclerosis [23] , and other diseases. Although, evidence from the literature indicates that both carriers and deficiency allele combinations for the PIS and PIZ defective alleles (namely PISS, PIMS, PIMZ, PISZ and PIZZ phenotypes) are at increased risk of developing the above mentioned AAT Deficiency-associated diseases clear scientific evidence of the relationship among PIMS and PISS phenotypes and these diseases remains to be established Knowledge of the AAT Deficiency prevalence in every community is essential for enhancing awareness of this disease among health-care givers and the general public, for planning health policy and financial medical resources, and to their utilization by the scientific community, governments and the pharmaceutical industry [1] . The present study utilizes data from genetic epidemiological studies performed by others to determine the phenotypes of carriers and deficiency allele combinations for PIS and PIZ in the control cohorts of individual case studies located at random in 14 out of the 20 regions in Italy. This is a unique database that was not found for any country in the original database on 58 countries [1] , or our current database on 67 countries worldwide (de Serres, unpublished).
We have used the genetic epidemiological studies to compare the deficiency allele frequencies of PIS and PIZ and their utilization, along with estimates of the population sizes in each of these 14 regions, to develop estimates, using Hardy-Weinberg statistical analyses, of the numbers of carriers (PIMS and PIMZ) and deficiency allele homozygotes and heterozygotes (PISS, PISZ, and PIZZ).
Methods

Sources of the control cohort data used in the present study
The present study utilizes data from genetic epidemiological studies performed by others to determine the frequencies of the phenotypes of carriers and deficiency allele combinations for PI S and PI Z, in the control cohorts of individual case studies from 14 different regions of Italy [2] . The data from these individual cohorts for a given region are combined to get mean frequencies for the PIM, PIS, and PIZ alleles and their prevalences. The allele frequencies are then used to calculate the total numbers of individuals in each of the five major defective phenotypic classes of interest (namely, PIMS, PIMZ, PISS, PISZ, and PIZZ) in the total population of each region. Our approach is a step beyond the data that typically are published, in which the gene frequencies for PIM, PIS, and PIZ were calculated and reported for individual cohorts in individual cities or geographic regions [1] .
The papers used in the present study were obtained through a variety of sources, and have been discussed in earlier publications [2] .
Estimating allele frequencies of PIM, PIS, and PIZ
The formulas developed by Dr. Bustillo for developing estimates of the allele frequencies and 95% confidence intervals using Hardy-Weinberg statistical analysis were discussed in an earlier paper [24] .
Development of a "Precision Factor Score" of statistical reliability for each control cohort
To assess the statistical reliability of the control cohorts in the surveys for each country, a Precision Factor Score with a scale of 1 to 12 was developed by one of us (EF Bustillo), as described in an earlier publication [2] . Since PFS is inversely proportional to the values of the coefficient of variation (cv), which measures the dispersion of values in respect to the mean, the smaller value of cv the greater PFS.
It is important to have in mind that a cv depends on the total number of alleles (sample size) and on the allele frequencies of PIS and PIZ actually found. Thus, a low score is the result of small numbers of subjects in a given control cohort, or a series of control cohorts each with a small number of subjects, and low values for PIS and/or PIZ allele frequencies. A high score is given to those studies where the number of subjects is high or a series of control cohorts each with a large number of subjects, and high values for PIS and/or PIZ allele frequencies. In addition, a statistical analysis of the total control cohort sample for a given country is performed to provide estimates of the mean, median, standard deviation, and the range (upper and lower values).
Results
Hardy-Weinberg statistical analysis of the control cohort databases for each of the 14 regions
Forty-three cohorts, having a total of 12,143 individuals, have been collected from database searches on each of these 14 regions in Italy [2] The overall database for each of the 14 regions is given in table 2 where the number of control cohorts in each region is given along with the PF Score, and the deficiency allele frequencies using Hardy-Weinberg statistical analysis with 95% confidence intervals. In addition, estimates are given of the prevalence for each of the 5 phenotypic classes: 3 considered to be at risk for adverse health effects (namely PIMZ, PISZ, and PIZZ) as well as 2 not currently considered to be at risk (namely PIMS and PISS).
Comparison of the deficiency allele frequencies for PIS in each of the 14 regions
When the deficiency allele frequencies for PIS for each of the regions are compared ( fig. 3) , there are 23 out of 84 comparisons (in black boxes) where the allelic frequencies are statistically different from one another.
Comparison of the deficiency allele frequencies for PIZ in each of the 14 regions
When the deficiency allele frequencies for PIZ for each of the regions are compared ( fig. 4) , there are 5 out of 84 comparisons (in black boxes) where the allelic frequencies are statistically different from one another.
Discussion
Geographic distribution of the PIS and PIZ deficiency alleles in Italy
The comparisons of the prevalences of each of the 5 phenotypic classes for both PIS and PIZ in table 2 indicate that there are striking differences from region to region. For example, for PIS there is a difference in prevalence of 1 out of 46 in Lazio in contrast to 1 out of 7 in Calabria, and for PIMZ there is a difference in prevalence of 1 out of 35 for Trentino and less than 1 out of 1 X10 6 in Calabria. The lower deficiency allele frequencies for PIZ as well as the sizes of the various control cohorts in some of these 14 regions makes statistical analyses less rigorous than for the deficiency PIS allele. Nevertheless, both comparisons demonstrate that the distribution of these 2 deficiency alleles throughout the whole country is quite different. Another factor worth noting is the fact that the PF Scores of the control cohort studies selected for this analysis are >4 indicating that they are very reliable. Earlier studies on the distribution of the PIS and PIZ deficiency alleles [25, 26] , based on smaller cohorts suggested higher deficiency allele frequencies for PIS and lower deficiency allele frequencies for PIZ in southern Europe than northern Europe.
In the present study, striking regional differences in the frequency of these two alleles were found for these 14 regions in Italy ( figs. 1 and 2) .
The high deficiency allele frequencies for PIS found in northern Italian regions are matched by high frequencies in six of the regions in central Italy (Emilia Romagna, Toscana, Umbria, Lazio, Campania, and Molise) (table 2). Lower deficiency allele frequencies for PIS were found for three of the southern Italian regions (Puglia, Calabria and Sicilia). It also is of interest that the deficien- fig. 2) . These same comparisons demonstrate that the PIZ frequencies for the remaining regions are not significantly different from one another (fig. 4) . This can be attributed primarily to the low frequencies of the PIZ deficiency allele throughout Italy as well as the larger cohort sample sizes needed to demonstrate any differences in these low PIZ frequencies.
It is well known that the country of Italy was settled in its early history by very diverse ethnic subgroups [27] many of which gave rise to the present names of the 20 individual regiones. It also is well known that in more recent times that Italy now includes small clusters of German-, French-, and Slovene-Italians in the north, and AlbanianItalians and Greek-Italians in the south. We have no information on the PIS and PIZ deficiency allele frequencies in the pre-Roman ethnic subgroups [27] . However, since the deficiency allele frequencies for PIS and PIZ were demonstrated to be quite different in the various European countries from which this latter group of immigrants were derived [1] , it is not unexpected that these deficiency allele frequencies would be different in the various regions where these immigrants settled.
The value of such studies on regional differences in the frequency of different genetic diseases also was demonstrated in a study of the idiopathic hemochromatosis gene frequency by Lindmark and Eriksson in Sweden [28] . In this study, striking differences also were found that were attributed to a difference in the population structure and composition of the local population in the county of Jämtland that were not representative of the entire country of Sweden.
We have used Hardy-Weinberg statistical analyses which assume random mating within given populations. It is clear that the model is inadequate for statistical analysis of the population of the whole country of Italy and raises the question as to whether it is suitable model for each of the 14 regions within Italy. This analysis has demonstrated striking differences of the prevalence of this disease in these 14 different regions in Italy. These differences, in turn, raise the issue of how to use such control cohort data to get a best estimate of the prevalence of AAT Deficiency in the whole county of Italy. This analysis also impacts the development of such estimates for the other countries in the overall country database worldwide [1] ,
Adverse health effects of the deficiency alleles PIS and PIZ
There is not general acceptance of the adverse health effects associated with the PIS deficiency allele as indicted in the ATS/ERS Standards document [29] . As a result we have treated the PIMS and PISS phenotypic classes as "not currently considered at risk". However, recent research articles [30, 31] provide documentation that both carriers (PIMS and PIMZ) and deficiency allele combinations (PISS, PISZ and PIZZ) may be at risk for various adverse health effects.
Adverse health effects of rare variants for AAT Deficiency in the Italian Registry
Among a total of 2,922 subjects in the Italian AAT Deficiency Registry, there were 155 subjects with severe AAT Deficiency (132 index cases), and 152 with intermediate AAT Deficiency (84 cases) [32] . Among the 132 subjects with severe AAT Deficiency, 15 out of 132 deficient index subjects were identified that were not PIZZ or PISZ, and among the 84 subjects with intermediate AAT Deficiency, 13 out of 84 had genotypes other than the more common genotype PIMZ.
Since these rare variants in the Italian AAT Deficiency Registry [32] have been characterized at the molecular level, they provided a unique and valuable resource for the study of their adverse health effects as well as making possible comparisons with the characteristics of the more common deficiency alleles PIS and PIZ.
Analysis of COPD prevalence and respiratory function indicated, for example, that COPD prevalence was higher in some of the newly discovered rare variant heterozygotes (with the PIM allele) than in PIMZ or PISZ subjects or higher in rare variant heterozygotes (with the PIZ deficiency allele) than PIZZ subjects.
Chronic liver disease, which is the second most common feature associated with AAT Deficiency, also was found to be comparable in the newly discovered rare heterozygotes (with the PIZ deficiency allele) as with PIZZ, PISZ and PIMZ subjects [32] .
Additional comparisons of the adverse health effects associated with these rare variants are particularly relevant since they have been found either in the same or closely related ethnic subgroups in different parts of the country of Italy.
AAT Deficiency Research needs
New research initiatives are needed to gain a better understanding of the differences in the adverse health effects associated with the same five phenotypic classes of AAT Deficiency in different individuals associated with the two most prevalent deficiency alleles PIS and PIZ. Equally important is the need to investigate any differences associated with the expression of this genetic disease in different racial subgroups. Such an approach may well resolve apparent differences in the adverse health effects reported in the medical literature on each of the five phenotypic classes of the PIS and PIZ deficiency alleles. The addition of large numbers of rare variants found within various regions in Italy stored in the Italian AAT Deficiency Registry provides a new and unique resource for the further investigation of the adverse health effects associated with other rare AAT Deficiency variants.
